L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus

Proceedings of the National Academy of Sciences of the United States of America
Emmanuel CormierTatjana Dragic

Abstract

Target cell tropism of enveloped viruses is regulated by interactions between viral and cellular factors during transmission, dissemination, and replication within the host. Binding of viral envelope glycoproteins to specific cell-surface receptors determines susceptibility to viral entry. However, a number of cell-surface molecules bind viral envelope glycoproteins without mediating entry. Instead, they serve as capture receptors that disseminate viral particles to target organs or susceptible cells. We and others recently demonstrated that the C type lectins L-SIGN and DC-SIGN capture hepatitis C virus (HCV) by specific binding to envelope glycoprotein E2. In this study, we use an entry assay to demonstrate that HCV pseudoviruses captured by L-SIGN+ or DC-SIGN+ cells efficiently transinfect adjacent human liver cells. Virus capture and transinfection require internalization of the SIGN-HCV pseudovirus complex. In vivo, L-SIGN is largely expressed on endothelial cells in liver sinusoids, whereas DC-SIGN is expressed on dendritic cells. Capture of circulating HCV particles by these SIGN+ cells may facilitate virus infection of proximal hepatocytes and lymphocyte subpopulations and may be essential for the establishment of persi...Continue Reading

References

Jun 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·Y K ShimizuH Yoshikura
Jan 26, 1995·Biochemical and Biophysical Research Communications·N KatoK Shimotohno
Jun 1, 1994·The Journal of Arthroplasty·Y NakabayashiM Griffin
Apr 1, 1993·The Journal of General Virology·H M MüllerL Theilmann
Jan 1, 1997·Infection and Immunity·K S Rostand, J D Esko
Jan 1, 1997·Advances in Experimental Medicine and Biology·B DuboisC Caux
Nov 15, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S IacovacciG Carloni
Oct 21, 1998·The Journal of General Virology·C FournierP Maurel
Jan 8, 1999·Research in Virology·C BosmanG Carloni
Apr 28, 1999·Trends in Microbiology·S UgoliniQ J Sattentau
May 3, 2000·The Journal of Experimental Medicine·F LechnerB D Walker
Feb 28, 2001·Proceedings of the National Academy of Sciences of the United States of America·S PöhlmannR W Doms
Jul 7, 2001·The New England Journal of Medicine·G M Lauer, B D Walker
Aug 24, 2001·The Journal of Clinical Investigation·D Shukla, P G Spear
Sep 11, 2001·The Journal of Infectious Diseases·J BoisvertH B Greenberg
Nov 1, 2001·Clinics in Liver Disease·M FlintS Levy
Dec 18, 2001·The Journal of Pathology·E J SoilleuxN Coleman
Dec 18, 2001·Medicinal Research Reviews·Jian Liu, Suzanne C Thorp
Feb 23, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Anneke EngeringYvette van Kooyk
Jun 7, 2002·Journal of Virology·Carmen P AlvarezRafael Delgado
Jul 23, 2002·Journal of Virology·Valérie CastetJean-Michel Pawlotsky
Jul 23, 2002·Journal of Virology·Honey V Reddi, Howard L Lipton
Mar 1, 2003·The Journal of Biological Chemistry·Pierre-Yves LozachRalf Altmeyer
Mar 5, 2003·The Journal of Experimental Medicine·Birke BartoschFrançois-Loïc Cosset
Mar 14, 2003·Journal of Virology·Stefan PöhlmannJane A McKeating

❮ Previous
Next ❯

Citations

May 7, 2008·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Ui-Soon KhooC L Steve Lin
Oct 24, 2009·Cell Biochemistry and Biophysics·Qiu-Li ChenZhong-Tian Qi
Jan 8, 2013·Cell Biochemistry and Biophysics·Lan-Juan ZhaoZhong-Tian Qi
Feb 5, 2013·Cell Stress & Chaperones·Lan-Juan ZhaoZhong-Tian Qi
Jun 14, 2005·Current Opinion in Immunology·Alessandra Cambi, Carl G Figdor
Apr 7, 2009·Nature Reviews. Gastroenterology & Hepatology·Ella H SklanJeffrey S Glenn
Oct 26, 2010·Nature Reviews. Immunology·Angus W Thomson, Percy A Knolle
Apr 8, 2010·Nature Reviews. Microbiology·Mélanie LambotinHeidi Barth
May 25, 2011·The Journal of Infectious Diseases·Wanwisa DejnirattisaiGavin Screaton
Jul 1, 2006·Journal of Virology·Ayaz M MajidGlen N Barber
Jun 19, 2009·Journal of Virology·Christof K SeckertNatascha K A Grzimek
May 16, 2006·Journal of Virology·George KoutsoudakisRalf Bartenschlager
Jun 16, 2005·Journal of Virology·Anne GoffardJean Dubuisson
Jan 18, 2006·Journal of Virology·Carl W DavisTheodore C Pierson
Oct 28, 2006·Annual Review of Immunology·Lynn B Dustin, Charles M Rice
Oct 3, 2013·The Journal of Clinical Investigation·Hugo R Rosen
Jan 28, 2009·Virology Journal·Katharina B Rothwangl, Lijun Rong
Aug 4, 2009·PLoS Pathogens·Giulia Freer, Donatella Matteucci
Jan 6, 2009·Uirusu·Takashi EbiharaTsukasa Seya
Mar 11, 2009·Frontiers in Bioscience (Landmark Edition)·Mirjam B ZeiselThomas F Baumert
Apr 22, 2015·Annual Review of Virology·Vyas RamananSangeeta N Bhatia
Dec 20, 2014·Cell Host & Microbe·Qiang DingAlexander Ploss
Feb 18, 2011·Journal of Gastroenterology·Angela Dolganiuc, Gyongyi Szabo
Nov 8, 2011·International Reviews of Immunology·Saifur RahmanPooja Jain
Mar 16, 2013·Gastroenterología y hepatología·George KoutsoudakisSofía Pérez-Del-Pulgar
Jul 1, 2009·Gastroenterology·Natalie A Counihan, Brett D Lindenbach
Dec 7, 2007·Trends in Immunology·Sandrine RoullandBertrand Nadel
Sep 11, 2007·Advanced Drug Delivery Reviews·Tetsuro SuzukiTakaji Wakita
Jun 2, 2007·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Vito Racanelli, Tobias Manigold

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Jason P GardnerWilliam C Olson
Proceedings of the National Academy of Sciences of the United States of America
Emmanuel CormierTatjana Dragic
© 2021 Meta ULC. All rights reserved